2Jocoby GA, Han P. Detection of extended-spectrum beta-lactamases in clinical isolates of Klebsiella pneumoniae and Escherichia coli[J]. Clin Microbiol, 1996, 34(4) :908-911.
3Hartstein AI, Denny MA, Morthland VH, et al. Control of methicillinresistant Staphylococcus aureus in a hospital and an intensive care unit.Infect Control Hosp Epidemiol, 1995, 16(7): 405-411.
4Bukharie HA, Abdelhadi MS, Saeed IA, et al. Emergence of methicillin-resistant Staphylococcus aureus as a community pathogen. Diagn-Microbiol-Infect-Dis, 2001, 40(1): 1-4.
5Livermore DM. Antibiotic resistance in staphylococci. Int J Antimicrob Agents, 2000, 16 (Suppl 1): 3-10.
6Salmenlinna S, Lyytikainen O, Vuopio-Varkila J. Community-acquired methicillin-resistant Staphylococus aureus, Finland. Emerging Infect Dis, 2002, 8(6): 602-607.
7Lencastre H, Matthews PR, Tomasz A, et al. Molecular aspects of methicillin resistance in Staphylococcus aureus. J Antimicrob Chemother,1994, 33(1): 7-24.
8Daum RS, Ito T, Hiramatsu K, et al. A novel methicillin-resistance cassette in community-acquired methicillin-resistant Staphylococcus aureus isolates of diverse genetic backgrounds. J Infect Dis, 2002, 186 (9):1344-1347.
9Almer LS, Shortidge VD, Nilius AM, et al. Antimicrobial susceptibility and molecular characterization of community-acquired methicillin-resistant Staphylococcus aureus. Diagn Microbiol Infect Dis, 2002, 43(3): 225-232.
10Bartley J. First case of VRSA identified in Michigan. Infect Control Hosp Epidemiol, 2002, 23(8): 480.
